Dubai: In line with objectives to enhance regional collaborations and support cancer patients in the UAE, US-based multinational pharmaceutical and biotechnology corporation, Pfizer recently signed an association deal with the UAE-based Friends of Cancer Patients (FOCP) and Emirates Oncology Society.
The Memorandum of Understanding strengthens Pfizer’s commitment to progressing oncology care, promoting early detection, and supporting cancer treatment in the country.
Cancer is one of the greatest health challenges we collectively face. Therefore, as part of our renewed commitment at Pfizer to Friends of Cancer Patients and Emirates Oncology Society, we want to ensure that we are doing everything we can across the UAE to support cancer patients. –Ms. Lindsey Dietschi, Pfizer’s Gulf Cluster Lead remarked about the ongoing association with Friends of Cancer Patients and Emirates Oncology Society.
According to Ms. Sawsan Jafar, Chairperson of FCOP’s Board of Directors, new treatments have played a critical part in UAE patients’ fight and survival against cancer, especially when detected early.
The rate of cancer patients is expected to grow two-fold in the Gulf Corporation Council (GCC) countries by 2025 compared to the rest of the world, Dr. Humaid al-Shamsi, President of Emirates Oncology Society observed while stressing that early detection remains the ‘first and most critical defense against cancer.’